Diabetic retinopathy in type 1 diabetics in the County of Frederiksborg;Diabetisk retinopati hos type 1-diabetikere i Frederiksborg Amt

Ugeskrift for Laeger

Volumn 165, Issue 30, 2003, Pages 2953-2956

  Jacobsen, Nina ^a   Kjer, Birgit E ^a   Goldschmidt, Ernst ^a   Andersen, Ole Ortved ^a   Thorsteinsson, Birger ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BLINDNESS; DIABETES MELLITUS; DIABETIC RETINOPATHY; HEALTH PROGRAM; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; PREVALENCE; RETINOPATHY; RISK FACTOR; SCREENING TEST; ADOLESCENT; COMORBIDITY; CROSS-SECTIONAL STUDY; DENMARK; FEMALE; FOLLOW UP; MALE; MASS SCREENING; MEDICAL AUDIT; PRACTICE GUIDELINE;

ADOLESCENT; ADULT; BLINDNESS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN; MALE; MASS SCREENING; MEDICAL AUDIT; PRACTICE GUIDELINES; RISK FACTORS;

EID: 0042885378     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aiello LP, Gardner TW, King GL et al. Diabetic retinopathy. Diabetes Care 1998;21:143-56.
2. Bachmann M, Nelson S. Screening for diabetic retinopathy: a quantitative overview of the evidence, applied to the population of health authorities and boards. Bristol: Health Care Evaluation Unit, 1996.
3. Rohan TE, Frost CD, Wald NJ. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. BMJ 1989;299:1198-201.
4. WHO. Prevention of Diabetes Mellitus: Report of a WHO study group, WHO technical report series No. 844. Geneva: WHO, 1994.
5. Sundhedsstyrelsen. Diabetesbehandling i Danmark - fremtidig organisering. København: Sundhedsstyrelsen, 1994.
6. Thorsteinsson B, Kirkegaard BC, Andersen OO. Kvalitetssikring i et diabetesambulatorium. Ugeskr Læger 1995;157:4335-9.
7. Klein R, Klein BE, Moss SE et al, The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107:237-43.
8. Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
9. Sjolie AK. Ocular complications in insulin treated diabetes mellitus. Acta Ophthalmol Suppl 1985;172:1-77.
10. Rossing K, Jacobsen P, Rossing P et al. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 1998;21:2007-15.
11. Kristinsson JK, Hauksdottir H, Stefansson E et al Active prevention in diabetic eye disease. Acta Ophthalmol Scand 1997;75:249-54.
12. Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
13. Klein R, Moss SE, Klein BE. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology 1993;100:1140-6.
14. Klein R, Klein BE, Moss SE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-15.
15. Knuiman MW, Welborn TA, McCann VJ et al. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986;35:1332-9.
16. Stephenson JM, Fuller JH, Viberti GC et al. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia 1995;38:599-603.